Genetic Architecture of Heart Disease in Rural Brazil

This study has been completed.

First Received on September 7, 2001. Last Updated on August 20, 2008 History of Changes

Sponsor:	National Heart, Lung, and Blood Institute (NHLBI)
Information provided by:	National Heart, Lung, and Blood Institute (NHLBI)
ClinicalTrials.gov Identifier:	NCT00023556

Purpose

To examine the genetics of human susceptibility to Chagas' disease, a leading cause of heart disease throughout Latin America.

Condition
Chagas Disease Heart Diseases Arrhythmia Heart Failure, Congestive

Study Type:

Observational

Resource links provided by NLM:

Genetics Home Reference related topics: Brugada syndrome short QT syndrome

MedlinePlus related topics: Arrhythmia Chagas Disease Heart Diseases Heart Failure

U.S. FDA Resources

Further study details as provided by National Heart, Lung, and Blood Institute (NHLBI):

Study Start Date:	September 2001
Study Completion Date:	August 2008
Primary Completion Date:	August 2008 (Final data collection date for primary outcome measure)

Eligibility

Criteria

No eligibility criteria

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00023556

Sponsors and Collaborators

Investigators

Investigator:

Sarah Williams-Blangero

Southwest Foundation for Biomedical Research

More Information

Publications:

ClinicalTrials.gov Identifier:	NCT00023556 History of Changes
Other Study ID Numbers:	982
Study First Received:	September 7, 2001
Last Updated:	August 20, 2008
Health Authority:	United States: Federal Government

Additional relevant MeSH terms:

Arrhythmias, Cardiac
Heart Diseases
Heart Failure
Chagas Disease
Cardiovascular Diseases

Pathologic Processes
Trypanosomiasis
Euglenozoa Infections
Protozoan Infections
Parasitic Diseases

ClinicalTrials.gov processed this record on February 09, 2012